Expression of insulin-like growth factor-I and insulin-like growth factor binding proteins during thioacetamide-induced liver cirrhosis in rats

Growth Hormone and IGF Research

Volumn 15, Issue 5, 2005, Pages 313-323

  Novosyadlyy, R ^a   Dargel, R ^b   Scharf, J G ^a,c  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

IGF binding proteins; IGF I; Liver cirrhosis; Thioacetamide

Indexed keywords

MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; IN SITU HYBRIDIZATION; INFLAMMATORY INFILTRATE; KUPFFER CELL; LIVER CELL; LIVER CIRRHOSIS; MYOFIBROBLAST; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, NORTHERN; ENDOTHELIAL CELLS; FEMALE; HEPATOCYTES; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR I; KUPFFER CELLS; LIVER CIRRHOSIS; RATS; RATS, WISTAR; RNA, MESSENGER; THIOACETAMIDE;

EID: 26044478185     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2005.06.015     Document Type: Article

References (60)

1. W.S. Cohick D.R. Clemmons The insulin-like growth factors Annu. Rev. Physiol. 55 1993 131-153
2. S. Shimasaki N. Ling Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6) Prog. Growth Factor Res. 3 1991 243-266
3. R.C. Baxter M.A. Binoux D.R. Clemmons et al. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily J. Clin. Endocrinol. Metab. 83 1998 3213
4. J.I. Jones D.R. Clemmons Insulin-like growth factors and their binding proteins: Biological actions Endocr. Rev. 16 1995 3-34
5. S.M. Firth R.C. Baxter Cellular actions of the insulin-like growth factor binding proteins Endocr. Rev. 23 2002 824-854
6. M.M. Rechler Insulin-like growth factor binding proteins Vitam. Horm. 47 1993 1-114
7. S.M. Twigg R.C. Baxter Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit J. Biol. Chem. 273 1998 6074-6079
8. J.G. Scharf F. Dombrowski G. Ramadori The IGF axis and hepatocarcinogenesis Mol. Pathol. 54 2001 138-144
9. R. Novosyadlyy K. Tron J. Dudas G. Ramadori J.G. Scharf Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts J. Cell Physiol. 199 2004 388-398
10. J.G. Scharf G. Ramadori T. Braulke H. Hartmann Cellular localization and hormonal regulation of biosynthesis of insulin-like growth factor binding proteins and of the acid-labile subunit within rat liver Prog. Growth Factor Res. 6 1995 175-180
11. J.G. Scharf T. Knittel F. Dombrowski et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells Hepatology 27 1998 1275-1284
12. E.M. Zimmermann L. Li E.C. Hoyt J.B. Pucilowska S. Lichtman P.K. Lund Cell-specific localization of insulin-like growth factor binding protein mRNAs in rat liver Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G447-G457
13. G. Buzzelli P. Dattolo M. Pinzani A. Brocchi S. Romano P. Gentilini Circulating growth hormone and insulin-like growth factor-I in nonalcoholic liver cirrhosis with or without superimposed hepatocarcinoma: Evidence of an altered circadian rhythm Am. J. Gastroenterol. 88 1993 1744-1748
14. A. Caufriez P. Reding D. Urbain J. Golstein G. Copinschi Insulin-like growth factor I: A good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis J. Endocrinol. Invest. 14 1991 317-321
15. S. Moller M. Gronbaek K. Main U. Becker N.E. Skakkebaek Urinary growth hormone (U-GH) excretion and serum insulin-like growth factor 1 (IGF-1) in patients with alcoholic cirrhosis J. Hepatol. 17 1993 315-320
16. J.G. Scharf F. Schmitz J. Frystyk et al. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease J. Hepatol. 25 1996 689-699
17. T. Hayakawa T. Kondo T. Shibata et al. Serum insulin-like growth factor II in chronic liver disease Dig. Dis. Sci. 34 1989 338-342
18. S. Moller A. Juul U. Becker A. Flyvbjerg N.E. Skakkebaek J.H. Henriksen Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis J. Clin. Endocrinol. Metab. 80 1995 1148-1157
19. J. Kratzsch W.F. Blum E. Schenker E. Keller Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins -1, -2, -3 and GH binding protein during progression of liver cirrhosis Exp. Clin. Endocrinol. Diabetes 103 1995 285-291
20. N. Assy Z. Hochberg T. Amit Z. Shen-Orr R. Enat Y. Baruch Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis J. Hepatol. 27 1997 796-802
21. C.L. Mendenhall S.D. Chernausek M.B. Ray et al. The interactions of insulin-like growth factor I(IGF-I) with protein-calorie malnutrition in patients with alcoholic liver disease: V.A. Cooperative study on alcoholic hepatitis VI Alcohol Alcohol. 24 1989 319-329
22. T. Inaba H. Saito T. Inoue et al. Growth hormone/insulin-like growth factor 1 axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy J. Hepatol. 31 1999 271-276
23. E. Shmueli M. Stewart K.G. Alberti C.O. Record Growth hormone, insulin-like growth factor-1 and insulin resistance in cirrhosis Hepatology 19 1994 322-328
24. E. Shmueli J.P. Miell M. Stewart K.G. Alberti C.O. Record High insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance Hepatology 24 1996 127-133
25. C.L. Mendenhall G.A. Roselle C.J. Grossman P. Gartside II: The effects of recombinant human insulin-like growth factor-1 on immunological recovery in the malnourished alcoholic rat Alcohol Clin. Exp. Res. 21 1997 1682-1689
26. F.J. Gallego-Rojo J.L. Gonzalez-Calvin M. Munoz-Torres J.L. Mundi R. Fernandez-Perez D. Rodrigo-Moreno Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis Hepatology 28 1998 695-699
27. S. Tanaka H. Tsurukami A. Sakai et al. Effects of 1,25(OH)2D3 on turnover, mineralization, and strength of bone in growing rats with liver cirrhosis induced by administration of carbon tetrachloride Bone 32 2003 275-283
28. G. Gayan-Ramirez C.M. van de H. Rollier et al. Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle J. Hepatol. 29 1998 241-249
29. I. Castilla-Cortazar M. Garcia J. Quiroga et al. Insulin-like growth factor-I reverts testicular atrophy in rats with advanced cirrhosis Hepatology 31 2000 592-600
30. I. Castilla-Cortazar N. Diez M. Garcia-Fernandez et al. Hematotesticular barrier is altered from early stages of liver cirrhosis: Effect of insulin-like growth factor 1 World J. Gastroenterol. 10 2004 2529-2534
31. I. Castilla-Cortazar M. Pascual E. Urdaneta et al. Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: Improvement by insulin-like growth factor I BMC Gastroenterol. 4 2004 12
32. I. Castilla-Cortazar M. Garcia B. Muguerza et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis Gastroenterology 113 1997 1682-1691
33. 4-cirrhotic rats is partially normalized by insulin-like growth factor-I Int. J. Biochem. Cell Biol. 34 2002 242-252
34. N.Z. Canturk Z. Canturk M. Ozden H. Dalcik M. Yardimoglu F. Tulubas Protective effect of IGF-1 on experimental liver cirrhosis-induced common bile duct ligation Hepatogastroenterology 50 2003 2061-2066
35. A. Gentilini F. Marra P. Gentilini M. Pinzani Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells J. Hepatol. 32 2000 227-234
36. T. Wang K. Shankar T.J. Bucci A. Warbritton H.M. Mehendale Diallyl sulfide inhibition of CYP2E1 does not rescue diabetic rats from thioacetamide-induced mortality Toxicol. Appl. Pharmacol. 173 2001 27-37
37. S.K. Ramaiah U. Apte H.M. Mehendale Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats Drug Metab. Dispos. 29 2001 1088-1095
38. C. Diez-Fernandez L. Bosca L. Fernandez-Simon A. Alvarez M. Cascales Relationship between genomic DNA ploidy and parameters of liver damage during necrosis and regeneration induced by thioacetamide Hepatology 18 1993 912-918
39. R.S. Mangipudy S. Chanda H.M. Mehendale Hepatocellular regeneration: Key to thioacetamide autoprotection Pharmacol. Toxicol. 77 1995 182-188
40. H. Petermann S. Vogl E. Schulze R. Dargel Chronic liver injury alters basal and stimulated nitric oxide production and 3H-thymidine incorporation in cultured sinusoidal endothelial cells from rats J. Hepatol. 31 1999 284-292
41. R.J. Ross S.L. Chew L.L. D'Souza et al. Expression of IGF-I and IGF-binding protein genes in cirrhotic liver J. Endocrinol. 149 1996 209-216
42. H.B. Richter H. Franke R. Dargel Expression of tenascin, fibronectin, and laminin in rat liver fibrogenesis - a comparative immunohistochemical study with two models of liver injury Exp. Toxicol. Pathol. 50 1998 315-322
43. S. Eyhorn H.J. Schlayer H.P. Henninger et al. Rat hepatic sinusoidal endothelial cells in monolayer culture. Biochemical and ultrastructural characteristics J. Hepatol. 6 1988 23-35
44. S. Vogl U. Junker H. Vogelsang R. Dargel Macrophages from rat livers with micronodular and macronodular cirrhosis differ with respect to mediator release and DNA-synthesis J. Hepatol. 26 1997 1093-1103
45. J.G. Scharf G. Ramadori F. Dombrowski Analysis of the IGF axis in preneoplastic hepatic foci and hepatocellular neoplasms developing after low-number pancreatic islet transplantation into the livers of streptozotocin diabetic rats Lab. Invest. 80 2000 1399-1411
46. J.G. Scharf T. Braulke H. Hartmann G. Ramadori Regulation of the components of the 150 kDa IGF binding protein complex in cocultures of rat hepatocytes and Kupffer cells 3′,5′-cyclic adenosine monophosphate J. Cell Physiol. 186 2001 425-436
47. J. Scharf G. Ramadori T. Braulke H. Hartmann Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: regulation by insulin, insulinlike growth factor, and growth hormone Hepatology 23 1996 818-827
48. H. Herbst S. Milani D. Schuppan H. Stein Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat Lab. Invest. 65 1991 324-333
49. S. Milani C. Grappone G. Pellegrini et al. Undulin RNA and protein expression in normal and fibrotic human liver Hepatology 20 1994 908-916
50. D. Cassiman L. Libbrecht V. Desmet C. Denef T. Roskams Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers J. Hepatol. 36 2002 200-209
51. G. Ramadori B. Saile Mesenchymal cells in the liver - one cell type or two? Liver 22 2002 283-294
52. M. Pinzani Novel insights into the biology and physiology of the Ito cell Pharmacol. Ther. 66 1995 387-412
53. K.L. Mohn A.E. Melby D.S. Tewari T.M. Laz R. Taub The gene encoding rat insulinlike growth factor-binding protein 1 is rapidly and highly induced in regenerating liver Mol. Cell Biol. 11 1991 1393-1401
54. J.G. Scharf F. Dombrowski R. Novosyadlyy et al. Insulin-like growth factor (IGF)-binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells Endocrinology 145 2004 3463-3472
55. J.I. Leu M.A. Crissey R. Taub Massive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient mice J. Clin. Invest. 111 2003 129-139
56. I. Demori S. Balocco A. Voci E. Fugassa Increased insulin-like growth factor binding protein-4 expression after partial hepatectomy in the rat Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G384-G389
57. T. Knittel D. Kobold B. Saile et al. Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential Gastroenterology 117 1999 1205-1221
58. C.J. Auernhammer C. Fottner D. Engelhardt M. Bidlingmaier C.J. Strasburger M.M. Weber Differential regulation of insulin-like growth factor-(IGF) I and IGF-binding protein (IGFBP) secretion by human peripheral blood mononuclear cells Horm. Res. 57 2002 15-21
59. Y. Gui L.J. Murphy Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): Demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma J. Clin. Endocrinol. Metab. 86 2001 2104-2110
60. B. Liu S.A. Weinzimer T.B. Gibson D. Mascarenhas P. Cohen Type Iα collagen is an IGFBP-3 binding protein Growth Horm. IGF Res. 13 2003 89-97